title: Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole.
abstract: Hyperprolactinemia can be a complication of conventional neurolepics as well as risperidone. We report the third case of attenuation of risperidone-induced hyperprolactinemia by aripiprazole.
authors.affiliation: Dent Neurologic Institute, University at Buffalo, Buffalo, NY, USA. mrainka@dentinstitute.com
authors.forename: M M
authors.initials: MM
authors.lastname: Rainka
authors.forename: H A
authors.initials: HA
authors.lastname: Capote
authors.forename: C A
authors.initials: CA
authors.lastname: Ross
authors.forename: F M
authors.initials: FM
authors.lastname: Gengo
mesh_terms: D000068180:Aripiprazole; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D017448:Receptors, Dopamine D2 / Q000187:drug effects; D018967:Risperidone / Q000009:adverse effects*
chemical_list: D010879:Piperazines; D015363:Quinolones; D017448:Receptors, Dopamine D2; D000068180:Aripiprazole; D018967:Risperidone